Medtronic announced FDA clearance for integrating its MiniMed insulin pump with Abbott's Freestyle Libre continuous glucose monitoring system. This interoperability aims to streamline diabetes management by providing seamless glucose data to pump users, enhancing automated insulin delivery and improving glycemic control. The approval is a milestone in connected diabetes care technologies, offering patients improved convenience and safety.